COVID-19 does not influence functional status after ARDS therapy.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
05 02 2023
Historique:
received: 11 11 2022
accepted: 22 01 2023
entrez: 5 2 2023
pubmed: 6 2 2023
medline: 8 2 2023
Statut: epublish

Résumé

Health-related quality of life after surviving acute respiratory distress syndrome has come into focus in recent years, especially during the coronavirus disease 2019 pandemic. A total of 144 patients with acute respiratory distress syndrome caused by COVID-19 or of other origin were recruited in a randomized multicenter trial. Clinical data during intensive care treatment and data up to 180 days after study inclusion were collected. Changes in the Sequential Organ Failure Assessment score were used to quantify disease severity. Disability was assessed using the Barthel index on days 1, 28, 90, and 180. Mortality rate and morbidity after 180 days were compared between patients with and without COVID-19. Independent risk factors associated with high disability were identified using a binary logistic regression. The SOFA score at day 5 was an independent risk factor for high disability in both groups, and score dynamic within the first 5 days significantly impacted disability in the non-COVID group. Mortality after 180 days and impairment measured by the Barthel index did not differ between patients with and without COVID-19. Resolution of organ dysfunction within the first 5 days significantly impacts long-term morbidity. Acute respiratory distress syndrome caused by COVID-19 was not associated with increased mortality or morbidity.

Identifiants

pubmed: 36740717
doi: 10.1186/s13054-023-04330-y
pii: 10.1186/s13054-023-04330-y
pmc: PMC9899507
doi:

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

48

Subventions

Organisme : AKF Program of the University of Tuebingen
ID : 414-0-0
Organisme : Deutsche Forschungsgemeinschaft
ID : DFG-RO 3671/8-1

Informations de copyright

© 2023. The Author(s).

Références

JPEN J Parenter Enteral Nutr. 2022 May;46(4):798-804
pubmed: 34343362
Intensive Care Med. 2006 Aug;32(8):1115-24
pubmed: 16783553
Behav Res Ther. 2017 Nov;98:4-18
pubmed: 27890222
Crit Care. 2015 Oct 02;19:356
pubmed: 26428615
J Am Geriatr Soc. 2021 Mar;69(3):696-703
pubmed: 33294986
Ann Am Thorac Soc. 2022 Feb;19(2):264-271
pubmed: 34214022
PLoS One. 2020 Dec 17;15(12):e0243883
pubmed: 33332386
Stat Med. 1991 Apr;10(4):585-98
pubmed: 2057657
Trials. 2020 Mar 4;21(1):242
pubmed: 32131881
Anaesth Crit Care Pain Med. 2020 Dec;39(6):740-741
pubmed: 33049394
Am J Respir Crit Care Med. 2006 Sep 1;174(5):538-44
pubmed: 16763220
J Intensive Care. 2016 Aug 11;4:56
pubmed: 27525106
Curr Opin Crit Care. 2018 Feb;24(1):35-40
pubmed: 29189296
Chin Med J (Engl). 2017 May 20;130(10):1161-1168
pubmed: 28485315
Crit Care Med. 2010 Jul;38(7):1554-61
pubmed: 20473149
JAMA. 2017 Jan 17;317(3):290-300
pubmed: 28114553
Thorax. 2018 Feb;73(2):125-133
pubmed: 28918401
J Intensive Care. 2019 Oct 30;7:48
pubmed: 31687161
Br J Anaesth. 2021 Mar;126(3):e110-e113
pubmed: 33413976
Intensive Care Med. 2022 Mar;48(3):343-351
pubmed: 35119497
Crit Care Med. 2016 Jul;44(7):1267-77
pubmed: 26992067
Clin Nutr. 2022 Dec;41(12):2934-2939
pubmed: 34893357
J Clin Epidemiol. 1989;42(8):703-9
pubmed: 2760661
J Infect. 2010 Dec;61(6):458-64
pubmed: 20797406
Ann Am Thorac Soc. 2021 Nov;18(11):1876-1885
pubmed: 33577740
Crit Care. 2019 Nov 27;23(1):374
pubmed: 31775846
JAMA. 2021 Apr 20;325(15):1525-1534
pubmed: 33729425
Ann Am Thorac Soc. 2021 Jul;18(7):1202-1210
pubmed: 33544045
Int J Qual Health Care. 2018 May 01;30(4):265-270
pubmed: 29385454
Front Surg. 2022 Mar 03;9:851113
pubmed: 35310429
Am J Respir Crit Care Med. 2017 Oct 15;196(8):1012-1020
pubmed: 28448162
Clin Interv Aging. 2020 Oct 13;15:1951-1961
pubmed: 33116449
Ann Intensive Care. 2022 Feb 20;12(1):16
pubmed: 35184214
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Ann Thorac Med. 2022 Jan-Mar;17(1):28-36
pubmed: 35198046
Crit Care. 2011;15(1):R28
pubmed: 21244671
Thorax. 2017 Apr;72(4):311-317
pubmed: 27440140
Nat Rev Dis Primers. 2019 Mar 14;5(1):18
pubmed: 30872586
N Engl J Med. 2003 Feb 20;348(8):683-93
pubmed: 12594312
Crit Care Med. 2015 Mar;43(3):642-53
pubmed: 25513784

Auteurs

Alice Bernard (A)

Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany.

Lina Maria Serna-Higuita (LM)

Institute for Clinical Epidemiology and Applied Biometry, Faculty of Medicine, University of Tübingen, Tübingen, Germany.

Peter Martus (P)

Institute for Clinical Epidemiology and Applied Biometry, Faculty of Medicine, University of Tübingen, Tübingen, Germany.

Valbona Mirakaj (V)

Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany.

Michael Koeppen (M)

Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany.

Alexander Zarbock (A)

Department of Anesthesiology, Intensive Care and Pain Medicine, University of Münster, Münster, Germany.

Gernot Marx (G)

Department of Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany.

Christian Putensen (C)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.

Peter Rosenberger (P)

Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany. peter.rosenberger@medizin.uni-tuebingen.de.

Helene Anna Haeberle (HA)

Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany. helene.haeberle@medizin.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH